136
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation

, MD, , MD, , , MD, , MD & , MD
Pages 2017-2024 | Published online: 23 Aug 2007

Bibliography

  • KORENY M, RIEDMULLER E, NIKFARDJAM M, SIOSTRZONEK P, MULLNER M: Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA (2004) 29:350-357.
  • PAN M, SUAREZ DE LEZO J, MEDINA A et al.: In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am. J. Cardiol. (1997) 80:1336-1338.
  • BRIGUORI C, DI MARIO C, DE GREGORIO J, SHEIBAN I, VAGHETTI M, COLOMBO A: Administration of protamine after coronary stent deployment. Am. Heart J. (1999) 138:64-68.
  • DUCAS J, CHAN MC, MILLER A, KASHOUR T: Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients. Catheter. Cardiovasc. Interv. (2002) 56:196-199.
  • THE GUSTO INVESTIGATORS: An international randomized trial comparing four thrombolitic strategies for acute myocardial infarction. N. Engl. J. Med. (1993) 329:673-682.
  • THE EPISTENT INVESTIGATORS: Evaluation of platelet IIb/IIIa inhibitor for stenting: randomised placebo-controlled and balloon-angioplasty-controlled trial to asses safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet (1998) 352:87-92.
  • ANDERSON HV, SHAW RE, BRINDIS RG et al.: Relationship between procedure indications and outcomes of percutaneous coronary interventions by American college of cardiology/American heart association task force guidelines. Circulation (2005) 112:2786-2791.
  • LAUER MA, KARWEIT JA, CASCADE EF, LIN ND, TOPOL EJ: Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997. Am. J. Cardiol. (2002) 89:924-929.
  • MILKOVICH G, GIBSON G: Economic impact of bleeding complications and the role of antithrombotic therapies in percutaneous coronary intervention. Am. J. Health Syst. Pharm. (2003) 60(14 Suppl. 3):S15-S21.
  • ARONOW HD, PEYSER PA, EAGLE KA et al.: Predictors of length of stay after coronary stenting. Am. Heart J. (2001) 142:799-805.
  • MORENO R, FERNANDEZ C, HERNANDEZ R et al.: Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J. Am. Coll. Cardiol. (2005) 15:954-959.
  • IAKOVOU I, SCHMIDT T, BONIZZONI E et al.: Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA (2005) 293:2126-2130.
  • MORICE MC, DUMAS P, LEFEVRE T, LOUBEYRE C, LOUVARD Y, PIECHAUD JF: Systematic use of transradial approach or suture of the femoral artery after angioplasty: attempt at achieving zero access site complications. Catheter. Cardiovasc. Interv. (2000) 51:417-421.
  • BALZER JO, SCHEINERT D, DIEBOLD T, HAUFE M, VOGL TJ, BIAMINO G: Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Catheter. Cardiovasc. Interv. (2001) 53:174-181.
  • DANGAS G, MEHRAN R, KOKOLIS S et al.: Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J. Am. Coll. Cardiol. (2001) 38:638-641.
  • WHITTON HOLLIS H Jr, REHRING TF: Femoral endarteritis associated with percutaneous suture closure: new technology, challenging complications. J. Vasc. Surg. (2003) 38:83-87.
  • EIDT JF, HABIBIPOUR S, SAUCEDO JF et al.: Surgical complications from hemostatic puncture closure devices. Am. J. Surg. (1999) 178:511-516.
  • SPROUSE LR II, BOTTA DM Jr, HAMILTON IN Jr: The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. J. Vasc. Surg. (2001) 33:688-693.

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.